Decoy Therapeutics Inc. (DCOY) earnings
Quarterly results of Decoy Therapeutics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Decoy Therapeutics Inc. is expected to report around November 16, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Decoy Therapeutics Inc. reported revenue of $227.6K and a net loss of $2.4M.
Diluted earnings per share were -$4.46.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $227.6K | - | -$2.4M | -$4.46 |
| Q1 FY2026 | - | - | -$2.2M | -$4.18 |
| Q4 FY2025 | - | - | -$9M | - |
| Q3 FY2025 | - | - | -$873.5K | -$1.81 |
| Q2 FY2025 | $0 | - | -$957.8K | -$81.21 |
| Q1 FY2025 | - | - | -$1.7M | -$240.07 |
| Q4 FY2024 | - | - | -$1.5M | - |
| Q3 FY2024 | - | - | -$972.1K | -$11.38 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report (amended) 10-K/A
- Annual report 10-K
When is Decoy Therapeutics Inc.'s next earnings date?
Decoy Therapeutics Inc. is expected to report around November 16, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
What were Decoy Therapeutics Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Decoy Therapeutics Inc. reported revenue of $227.6K and a net loss of $2.4M. The figures come from its filing with the SEC.
Get an email when DCOY reports
Follow DCOY and we email you its next results the day they are filed, with the numbers explained.